Actinium Ac 225-ABD147
Term · Oncology and biomedicine · MLC-T-ONC-009622
A radioimmunoconjugate consisting of ABD147, an antibody fragment directed against the tumor-associated antigen (TAA) delta-like protein 3 (DLL3) conjugated with a linker-chelator to the alpha-emitting radioisotope actinium Ac 225 (225Ac), with potential antineoplastic activity. Upon administration of actinium Ac 225-ABD147, ABD147 targets and binds to DLL3 on DLL3-expressing tumor cells. Upon binding, the radioisotope moiety delivers a cytotoxic dose of alpha radiation to DLL3-expressing tumor cells. DLL3, a Notch pathway protein, is overexpressed on a variety of cancer cell types. It plays a key role in embryonic development and in tumor initiation and proliferation.
| Identifier | MLC-T-ONC-009622 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | 225Ac-ABD147 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-009622",
"term": "Actinium Ac 225-ABD147",
"field": "Oncology and biomedicine",
"definition": "A radioimmunoconjugate consisting of ABD147, an antibody fragment directed against the tumor-associated antigen (TAA) delta-like protein 3 (DLL3) conjugated with a linker-chelator to the alpha-emitting radioisotope actinium Ac 225 (225Ac), with potential antineoplastic activity. Upon administration of actinium Ac 225-ABD147, ABD147 targets and binds to DLL3 on DLL3-expressing tumor cells. Upon binding, the radioisotope moiety delivers a cytotoxic dose of alpha radiation to DLL3-expressing tumor cells. DLL3, a Notch pathway protein, is overexpressed on a variety of cancer cell types. It plays a key role in embryonic development and in tumor initiation and proliferation.",
"synonyms": [
"225Ac-ABD147"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/actinium-ac-225-abd147/"
}
Record 299 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.